Development of peptidomimetic hydroxamates as PfA-M1 and PfA-M17 dual inhibitors:Biological evaluation and structural characterization by cocrystallization
development、evaluation、inhibitors、cocr、dual、biological、character、crystallization、hydroxamates、peptidomimetic
33
S;O621.3+3;H315.9
2022-07-01(万方平台首次上网日期,不代表论文的发表时间)
共5页
2550-2554